Skip to main content
padlock icon - secure page this page is secure

Sustained Proangiogenic Activity of Vascular Endothelial Growth Factor Following Encapsulation in Nanoparticles

Buy Article:

$106.67 + tax (Refund Policy)

The success of proangiogenic growth factors for therapeutic angiogenesis in the treatment of ischemic diseases is currently hindered, in part, due to the lack of an optimal drug delivery system that can provide sustained therapeutic doses of these agents selectively in the diseased tissue. The objective of this study was to investigate the efficacy of sustained release biodegradable nanoparticles, formulated with poly (D,L-lactide-co-glycolide) polymer, for the delivery of vascular endothelial growth factor protein (VEGF), a potent proangiogenic agent. The hypothesis was that nanoparticles would protect the growth factor from degradation and release it slowly thereby sustaining and enhancing its proangiogenic effect. Nanoparticles encapsulating VEGF, which were formulated using a water-in-oil-in-water solvent evaporation technique, demonstrated sustained release of the growth factor in bioactive form. Further, the growth factor encapsulated in nanoparticles demonstrated greater and more sustained effect than when used as a solution on endothelial cell proliferation, migration, and morphogenesis, the key elements of angiogenesis. The greater efficacy of the growth factor encapsulated in nanoparticles was due to the ability of nanoparticles to maintain the growth factor level in culture for a sustained period of time. The data thus suggest that nanoparticles can be used as an effective delivery system for growth factors to induce therapeutic angiogenesis.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Keywords: ANGIOGENESIS; DRUG DELIVERY; ISCHEMIA; POLYMER; SUSTAINED RELEASE; VEGF

Document Type: Research Article

Publication date: March 1, 2005

More about this publication?
  • Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more